Interaction between angiotensin II, osteoprotegerin, and peroxisome proliferator-activated receptor-γ in abdominal aortic aneurysm

Journal of Vascular Research

Volumn 46, Issue 3, 2009, Pages 209-217

  Moran, Corey S ^a   Cullen, Bradford ^a   Campbell, Julie H ^b   Golledge, Jonathan ^a  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Abdominal aortic aneurysm; Angiotensin II; AT1 receptor; Metalloproteinase 9; Osteoprotegerin; PPAR ; Smooth muscle cells

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; APOLIPOPROTEIN E; GELATINASE B; OSTEOPROTEGERIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE;

ABDOMINAL AORTA ANEURYSM; ADRENAL GLAND; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; AORTA MEDIA; AORTA WALL; ARTICLE; CELL CULTURE; CELL EXPANSION; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; EXPLANT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFUSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; SMOOTH MUSCLE FIBER;

ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; HUMANS; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; OSTEOPROTEGERIN; PPAR GAMMA; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 53849122693     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000163019     Document Type: Article

References (31)

1. Golledge J, Muller J, Daugherty A, Norman P: Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 2006;26:2605-2613.
2. Shimizu K, Libby P, Mitchell RN: Local cytokine environments drive aneurysm formation in allografted aortas. Trends Cardiovasc Med 2005;15:142-148.
3. Moran CS, McCann M, Karan M, Norman PE, Ketheesan N, Golledge J: Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation 2005;111:3119-125.
4. Martens FM, Visseren FL, Lemay J, de Koning EJ, Rabelink TJ: Metabolic and additional vascular effects of thiazolidinediones. Drugs 2002;62:1463-1480.
5. Fu M, Zhang J, Lin Yg Y, Zhu X, Willson TM, Chen YE: Activation of peroxisome proliferator-activated receptor γ inhibits osteoprotegerin gene expression in human aortic smooth muscle cells. Biochem Biophys Res Commun 2002;294:597-601.
6. Zhang J, Fu M, Myles D, Zhu X, Du J, Cao X, Chen YE: PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways. FEBS Lett 2002;521:180-184.
7. Tao L, Liu HR, Gao E, Teng ZP, Lopez BL, Christopher TA, Ma XL, Batinic-Haberle I, Willette RN, Ohlstein EH, Yue TL: Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-γ agonist in hypercholesterolemia. Circulation 2003;108:2805-2811.
8. Cipollone F, Fazia M, Iezzi A, Pini B, Cuccurullo C, Zucchelli M, de Cesare D, Ucchino S, Spigonardo F, De Luca M, Muraro R, Bei R, Bucci M, Cuccurullo F, Mezzetti A: Blockade of the AngII type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity. Circulation 2004;109:1482-1488.
9. Budde K, Neumayer HH, Fritsche L, Sulowicz W, Stompor T, Eckland D: The pharmacokinetics of pioglitazone in patients with impaired renal function. Br J Clin Pharmacol 2003;55:368-374.
10. Clancy P, Oliver L, Jayalath R, Buttner P, Golledge J: Assessment of a serum assay for quantification of abdominal aortic calcification. Arterioscler Thromb Vasc Biol 2006;26:2574-2576.
11. Bernier NJ, Perry SF: Angiotensins stimulate catecholamine release from the chromaffin tissue of the rainbow trout. Am J Physiol 1997;273:R49-R57.
12. UK Small Aneurysm Trial Participants: Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 1998;352:1649-1655.
13. Daugherty A, Manning MW, Cassis LA: AngII promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000;105:1605-1612.
14. Nishimoto M, Takai S, Fukumoto H, Tsunemi K, Yuda A, Sawada Y, Yamada M, Jin D, Sakaguchi M, Nishimoto Y, Sasaki S, Miyazaki M, et al: Increased local AngII formation in aneurysmal aorta. Life Scie 2002;71:2195-2205.
15. Davies MJ: Aortic aneurysm formation: lessons from human studies and experimental models. Circulation 1998;98:193-195.
16. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW: Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000;105:1641-1649.
17. -/- mice. Ann N Y Acad Sci 1999;892:108-118.
18. Manning MW, Cassis LA, Huang J, Szilvassy SJ, Daugherty A: Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease. Vasc Med 2002;7:45-54.
19. Gavrila D, Li WG, McCormick ML, Thomas M, Daugherty A, Cassis LA, Miller FJ Jr, Oberley LW, Dellsperger KC, Weintraub NL: Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005;25:1671-1677.
20. Saraff K, Babamusta F, Cassis LA, Daugherty A: Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003;23:1621-1626.
21. Daugherty A, Cassis LA: Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2004;24:429-434.
22. Simonet WS, Lacey DL, Dunstan CR, Kelly M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennet L, Boone T, Shimamoto G, DeRose M, et al: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-319.
23. Theoleyre S, Wittrant Y, Couillaud S, Vusio P, Berreur M, Dunstan C, Blanchard F, Redini F, Heymann D: Cellular activity and signalling induced by Osteoprotegerin in osteoclasts: involment of receptor activator of nuclear factor κB ligand and MAPK. Biochim Biophys Acta 2004;1644:1-7.
24. Collin-Osdoby P: Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 2004;95:1046-1057.
25. Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M, Nussberger J, Harringer W, Drexler H: Expression of AngII and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 2000;101:1372-1378.
26. Martin MM, Buckenberger JA, Jiang J, Malana GE, Knoell DL, Feldman DS, Elton TS: TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways. Am J Physiol Lung Cell Mol Physiol 2007;293:L790-L799.
27. Cowling RT, Gurantz D, Peng JF, Dillmann WH, Greenberg BH: Transcription factor NF-κB is necessary for up-regulation of type 1 angiotensin II receptor mRNA in rat cardiac fibroblasts treated with tumor necrosis factor-α or interleukin-1β. J Biol Chem 2002;277:5719-5724.
28. Sugawara A, Takeuchi K, Uruno A, Ikeda Y, Arima S, Kudo M, Sato K, Taniyama Y, Ito S: Transcriptional suppression of type 1 AngII receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells. Endocrinology 2001;142:3125-3134.
29. Sugawara A, Takeuchi K, Uruno A, Kudo M, Sato K, Ito S: Effects of mitogen-activated protein kinase pathway and co-activator CREP-binding protein on peroxisome proliferator-activated receptor-γ-mediated transcription suppression of AngII type 1 receptor gene. Hypertens Res 2003;26:623-628.
30. Schupp M, Janke J, Clasen R, Unger T, Kintscher U: Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 2004;109:2054-2057.
31. Tham DM, Martin-McNulty B, Wang YX, Wilson DW, Vergona R, Sullivan ME, Dole W, Rutledge JC: AngII is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiol Genomics 2002;11:21-30.